Structural Basis of chemokine CXCL1 recognition with CXCR2 receptor
趋化因子 CXCL1 与 CXCR2 受体识别的结构基础
基本信息
- 批准号:10488181
- 负责人:
- 金额:$ 20万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-09-13 至 2024-08-31
- 项目状态:已结题
- 来源:
- 关键词:Acute DiseaseAddressAffinityAutomobile DrivingBindingBinding ProteinsBinding SitesBrainCCR5 geneCCR6 geneCXCL1 geneCXCR4 geneCellular AssayCharacteristicsChargeChronic DiseaseClinicalCommunicable DiseasesComplexCoupledCryoelectron MicroscopyCrystallizationDataDiseaseDockingFunctional disorderG-Protein-Coupled ReceptorsGTP-Binding Protein alpha Subunits, GsGTP-Binding ProteinsGrantHeartHumanHybridsHydrophobicityIL8 geneIL8RB geneInfectionInflammatoryInjuryInterleukin-8B ReceptorKnowledgeLungMeasurementMeasuresMediatingMethodsMolecularMolecular ConformationMotionN-terminalNMR SpectroscopyNatureNeutrophil InfiltrationNuclear Magnetic ResonanceOrganOutcomePlayProcessProteinsReceptor ActivationResearch ProposalsRoleSequence AnalysisSignal TransductionSiteSpecificityStructural ModelsStructureTestingTherapeuticTissuesVariantbasebeta-arrestinchemokinechemokine receptordesigndimerdrug developmentextracellularflexibilityinsightmolecular dynamicsmonomermutantneutrophilpublic health relevancereceptorresponsespatiotemporaltooltrafficking
项目摘要
Chemokine CXCL1, and its receptor CXCR2, a class-A G protein-coupled receptor (GPCR), play a
crucial role in directing blood neutrophils to sites of infection and injury. A dysregulation in CXCR2
activation results in host tissue damage and disease. CXCL1 binds CXCR2 at two distinct sites: N-
terminal domain (Site-I, unique to chemokines) and a groove defined by the receptor extracellular
loops/transmembrane helices (Site-II, shared with all class A receptors). The molecular basis by
which chemokine binding two distinct sites determine CXCR2 activation is not known. Structures and
sequence analyses reveal that chemokine and receptor residues that mediate binding are either
unstructured or conformationally dynamic. We propose that CXCL1 binding at Site-I of CXCR2, the
initial obligatory step, triggers structural and dynamic changes that are essential for Site-II
interactions. We will test our hypothesis using a hybrid strategy that combines nuclear magnetic
resonance (NMR) spectroscopy and molecular dynamics (MD) simulations. We will determine the
structure and characterize the role of conformational dynamics of Site-I CXCL1-CXCR2 N-terminal
domain complex using NMR spectroscopy (Aim 1). We will generate a structural model of CXCL1
bound to CXCR2 at the N-terminal domain by merging Site-I NMR structure and previously
determined CXCR2 structure, and use extended MD simulations to describe how CXCL1 bound at
Site-I engages the receptor at Site-II (Aim 2). We will characterize how CXCL1 Site-I and Site-II
residues identified from Aims 1 and 2 mediate CXCR2 activation using cellular assays (Aim 3). These
studies will provide critical insights into the molecular mechanisms underlying CXCR2 activation and
will advance designing therapeutics that disrupt CXCR2 activation and alleviate disease.
趋化因子CXCL 1及其受体CXCR 2,一种A类G蛋白偶联受体(GPCR),在细胞内发挥作用。
在将血液中性粒细胞引导至感染和损伤部位方面起着至关重要的作用。CXCR 2失调
激活导致宿主组织损伤和疾病。CXCL 1在两个不同的位点结合CXCR 2:
末端结构域(位点-I,趋化因子特有)和由受体胞外限定的沟
环/跨膜螺旋(位点II,与所有A类受体共享)。分子基础,
哪种趋化因子结合两个不同的位点决定CXCR 2的活化尚不清楚。结构和
序列分析表明,趋化因子和受体残基介导的结合,
非结构化或构象动态。我们认为CXCL 1与CXCR 2的I位点结合,
最初的强制性步骤,触发对站点II至关重要的结构和动态变化
交互.我们将使用一种混合策略来测试我们的假设,
共振(NMR)光谱和分子动力学(MD)模拟。康贝特人将以
CXCL 1-CXCR 2 N-末端I位点的结构和构象动力学特征
域复合物使用NMR光谱(目的1)。我们将生成CXCL 1的结构模型
通过合并位点-I NMR结构和先前的
确定的CXCR 2结构,并使用扩展的MD模拟来描述CXCL 1如何在
位点-I与位点-II处的受体接合(目的2)。我们将描述CXCL 1站点I和站点II
从目的1和2鉴定的残基使用细胞测定介导CXCR 2活化(目的3)。这些
这些研究将为CXCR 2激活的分子机制提供重要的见解,
将促进设计破坏CXCR 2激活和减轻疾病的治疗方法。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Krishna Rajarathnam其他文献
Krishna Rajarathnam的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Krishna Rajarathnam', 18)}}的其他基金
Structural Basis of chemokine CXCL1 recognition with CXCR2 receptor
趋化因子 CXCL1 与 CXCR2 受体识别的结构基础
- 批准号:
10218891 - 财政年份:2021
- 资助金额:
$ 20万 - 项目类别:
Malvern MicroCal PEAQ Isothermal Titration Calorimeter
Malvern MicroCal PEAQ 等温滴定量热仪
- 批准号:
9274599 - 财政年份:2017
- 资助金额:
$ 20万 - 项目类别:
Chemokine CXCL17 and Mucosal Immunosurveillance
趋化因子 CXCL17 和粘膜免疫监视
- 批准号:
8391500 - 财政年份:2012
- 资助金额:
$ 20万 - 项目类别:
Chemokine CXCL17 and Mucosal Immunosurveillance
趋化因子 CXCL17 和粘膜免疫监视
- 批准号:
8519289 - 财政年份:2012
- 资助金额:
$ 20万 - 项目类别:
Role of chemokine monomer-dimer equilibrium in innate immunity and inflammation
趋化因子单体-二聚体平衡在先天免疫和炎症中的作用
- 批准号:
7793450 - 财政年份:2006
- 资助金额:
$ 20万 - 项目类别:
Role of chemokine monomer-dimer equilibrium in innate immunity and inflammation
趋化因子单体-二聚体平衡在先天免疫和炎症中的作用
- 批准号:
7221286 - 财政年份:2006
- 资助金额:
$ 20万 - 项目类别:
Role of chemokine monomer-dimer equilibrium in innate immunity and inflammation
趋化因子单体-二聚体平衡在先天免疫和炎症中的作用
- 批准号:
7417794 - 财政年份:2006
- 资助金额:
$ 20万 - 项目类别:
Role of chemokine monomer-dimer equilibrium in innate immunity and inflammation
趋化因子单体-二聚体平衡在先天免疫和炎症中的作用
- 批准号:
7083124 - 财政年份:2006
- 资助金额:
$ 20万 - 项目类别:
Role of chemokine monomer-dimer equilibrium in innate immunity and inflammation
趋化因子单体-二聚体平衡在先天免疫和炎症中的作用
- 批准号:
7616178 - 财政年份:2006
- 资助金额:
$ 20万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 20万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 20万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 20万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 20万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 20万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 20万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 20万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 20万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 20万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 20万 - 项目类别:
Research Grant